Data driven HIV programming to maximise health benefits
SOURCE: Lancet HIV
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2020
TITLE AUTHOR(S): R.V.Barnabas, H.Van Rooyen
KEYWORDS: ANTIRETROVIRAL THERAPY (ART), COVID-19, HIV/AIDS, MEDICAL TREATMENT METHODS
DEPARTMENT: Impact Centre (IC), Impact Centre (PRESS), Impact Centre (CC)
Print: HSRC Library: shelf number 11585
HANDLE: 20.500.11910/15443
URI: http://hdl.handle.net/20.500.11910/15443
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2020
TITLE AUTHOR(S): R.V.Barnabas, H.Van Rooyen
KEYWORDS: ANTIRETROVIRAL THERAPY (ART), COVID-19, HIV/AIDS, MEDICAL TREATMENT METHODS
DEPARTMENT: Impact Centre (IC), Impact Centre (PRESS), Impact Centre (CC)
Print: HSRC Library: shelf number 11585
HANDLE: 20.500.11910/15443
URI: http://hdl.handle.net/20.500.11910/15443
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.
Abstract
From the perspective of the ongoing COVID-19 pandemic, where evidence on effective prevention and treatment interventions for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is limited, the near perfect efficacy of antiretroviral therapy (ART) for HIV treatment is enviable. ART prevents individual level HIV-associated morbidity and mortality, restoring life expectancy to near normal, and prevents transmissions by decreasing viral load to undetectable levels. To translate ART efficacy to population level health benefits, the Joint United Nations Programme on HIV/AIDS (UNAIDS) set goals to diagnose 90% of people living with HIV, link 90% of those diagnosed to ART, and achieve 90% viral suppression among people on ART by 2020. In the 6 years since UNAIDS set the 90-90-90 goal, four large community randomised trials tested ART as a strategy to decrease HIV incidence with mixed results.-
Related Research Outputs:
- The psychology of "cure": unique challenges to consent processes in HIV cure research in South Africa
- Maternal factors associated with infant neurodevelopment in HIV-exposed uninfected infants
- Adolescent human immunodeficiency virus self-management: associations with treatment adherence, viral suppression, sexual risk behaviours and health-related quality of life
- Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study
- PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study
- Towards achieving the 90-90-90 HIV targets: results from the South African 2017 national HIV survey
- HIV drug resistance profile in South Africa: findings and implications from the 2017 national HIV household survey
- Drug-resistant HIV in South Africa: status and response
- Being ALHIV and staying alive: what do we know about adolescents living with HIV in South Africa?
- Universal test and treat not enough to end HIV epidemic
- How community ART delivery may improve HIV treatment outcomes: qualitative inquiry into mechanisms of effect in a randomized trial of community-based ART initiation, monitoring and re-supply (DO ART) in South Africa and Uganda
- Global HIV efforts need to focus on key populations in LMICs
- Association between ART adherence and mental health: results from a national HIV sero-behavioural survey in South Africa
- Understanding factors influencing utilization of HIV prevention and treatment services among patients and providers in a heterogeneous setting: a qualitative study from South Africa
- Is there risk compensation among HIV infected youth and adults 15 years and older on antiretroviral treatment in South Africa?: findings from the 2017 national HIV prevalence, incidence, behaviour and communication survey
- Dilemmas in ethics and artifact: a South African perspective
- HIV clinical trials: ethics, human rights and social challenges
- Completion of the tuberculosis care cascade in a community-based HIV linkage linkage-to-care study in South Africa and Uganda
- Perspectives of healthcare professionals of the neuropsychiatric side effects associated with efavirenz and its management
- Achieving 90-90-90: a focus on sero-discordant couples